Finally, the antitumor activities of naïve nontreated and IL-2/HSP70-treated NK cells were evaluated and compared by MRI, showing effectiveness of treated NK cells manifested by tumor shrinkage, both after intracranial and systemic injection. This evidence concerns the gene IL2 and neoplasm.